Theodosios D Filippatos Selected Research

Hypolipidemic Agents (Antihyperlipidemics)

1/2019	Emerging Fixed-Dose Combination Treatments for Hyperlipidemia.
1/2018	Hypolipidemic Drugs and Diabetes Mellitus-Mechanisms and Data From Genetic Trials.
1/2014	Recommendations for severe hypertriglyceridemia treatment, are there new strategies?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Theodosios D Filippatos Research Topics

Disease

15	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 06/2006
8	Type 2 Diabetes Mellitus (MODY) 01/2022 - 03/2010
8	Dyslipidemias (Dyslipidemia) 09/2017 - 07/2007
7	Hyponatremia 07/2021 - 09/2013
5	Heart Failure 03/2019 - 04/2008
5	Body Weight (Weight, Body) 01/2019 - 02/2015
5	Hyperlipidemias (Hyperlipidemia) 01/2019 - 09/2005
5	Atherosclerosis 01/2018 - 01/2008
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2012 - 04/2006
4	Hypertriglyceridemia 01/2019 - 07/2006
4	Acute Kidney Injury (Acute Renal Failure) 01/2019 - 01/2008
4	Hypercholesterolemia 01/2019 - 03/2010
4	Neoplasms (Cancer) 01/2018 - 01/2008
4	Diabetes Mellitus 01/2018 - 03/2008
4	Weight Loss (Weight Reduction) 01/2017 - 01/2008
3	Hypertension (High Blood Pressure) 01/2022 - 01/2018
3	Infections 01/2019 - 10/2011
3	Albuminuria 01/2019 - 01/2015
3	Diabetic Nephropathies (Diabetic Nephropathy) 01/2019 - 10/2013
3	Hypoglycemia (Reactive Hypoglycemia) 01/2018 - 10/2013
3	Insulin Resistance 01/2017 - 09/2005
3	Pancreatitis 11/2014 - 01/2014
3	Non-alcoholic Fatty Liver Disease 10/2011 - 01/2008
2	Urinary Tract Infections (Urinary Tract Infection) 01/2019 - 02/2015
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2018 - 02/2015
2	Vascular Diseases (Vascular Disease) 09/2017 - 03/2008
2	Stroke (Strokes) 01/2017 - 07/2006
2	Demyelinating Diseases (Demyelinating Disease) 01/2017 - 06/2016
2	Hyperkalemia 04/2016 - 05/2015
2	Inappropriate ADH Syndrome (SIADH) 04/2016 - 02/2016
2	Neurologic Manifestations (Neurological Manifestations) 02/2016 - 09/2013
2	Prediabetic State (Prediabetes) 01/2016 - 06/2013
2	Headache (Headaches) 11/2014 - 07/2007
2	Pancreatic Neoplasms (Pancreatic Cancer) 11/2014 - 06/2014
2	Abdominal Pain (Pain, Abdominal) 01/2014 - 01/2008
2	Overweight 10/2011 - 08/2008
2	Obesity 03/2010 - 01/2010
2	Rheumatoid Arthritis 10/2009 - 05/2006
1	Thrombocytopenia (Thrombopenia) 10/2021
1	Atherosclerotic Plaque (Atheroma) 01/2019

Drug/Important Bio-Agent (IBA)

10	LipidsIBA 01/2018 - 09/2005
9	ElectrolytesIBA 07/2021 - 12/2005
8	SodiumIBA 07/2021 - 12/2005
8	Pharmaceutical PreparationsIBA 01/2019 - 05/2006
8	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019 - 04/2008
7	Triglycerides (Triacylglycerol)IBA 01/2019 - 07/2007
7	LDL CholesterolIBA 09/2017 - 04/2006
7	Lipoproteins (Lipoprotein)IBA 08/2013 - 05/2006
7	Rosuvastatin Calcium (Crestor)FDA Link 12/2011 - 09/2005
6	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 06/2013
6	oxidized low density lipoproteinIBA 01/2017 - 04/2006
5	HDL CholesterolIBA 01/2019 - 07/2006
5	Orlistat (Xenical)FDA Link 10/2011 - 01/2008
4	Sodium-Glucose Transporter 2 InhibitorsIBA 03/2019 - 04/2017
4	Fibric Acids (Fibrates)IBA 01/2019 - 08/2013
4	HDL LipoproteinsIBA 01/2019 - 10/2011
4	Ezetimibe (Zetia)FDA Link 01/2019 - 03/2011
4	Hypoglycemic Agents (Hypoglycemics)IBA 01/2019 - 10/2009
4	Drug CombinationsIBA 01/2019 - 03/2010
4	Fenofibrate (CiL)FDA LinkGeneric 01/2015 - 08/2008
3	CalciumIBA 03/2019 - 12/2005
3	Hypolipidemic Agents (Antihyperlipidemics)IBA 01/2019 - 01/2014
3	Uric Acid (Urate)IBA 01/2019 - 09/2005
3	Insulin (Novolin)FDA Link 01/2018 - 01/2014
3	ApolipoproteinsIBA 01/2017 - 07/2006
3	Vasopressins (Vasopressin)IBA 01/2017 - 02/2016
3	CholesterolIBA 01/2017 - 10/2011
2	DiureticsIBA 03/2019 - 02/2016
2	dapagliflozinIBA 01/2019 - 02/2015
2	LDL Lipoproteins (beta Lipoproteins)IBA 01/2017 - 10/2011
2	ThiazidesIBA 01/2017 - 02/2016
2	Simvastatin (Zocor)FDA LinkGeneric 01/2016 - 01/2015
2	AcidsIBA 05/2015 - 12/2005
2	Metformin (Glucophage)FDA LinkGeneric 02/2015 - 11/2014
2	HomocysteineIBA 01/2015 - 09/2005
2	CreatinineIBA 01/2015 - 09/2005
2	Exenatide (Byetta)FDA Link 11/2014 - 10/2013
2	Glucagon-Like Peptide 1 (GLP 1)IBA 11/2014 - 10/2013
2	Glucagon-Like Peptide-1 Receptor AgonistsIBA 11/2014 - 10/2013
2	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 07/2014 - 09/2013
2	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2014 - 12/2011
2	Niacin (Nicotinic Acid)FDA LinkGeneric 01/2014 - 03/2011
2	EnzymesIBA 06/2013 - 10/2011
2	Apolipoproteins AIBA 10/2011 - 07/2006
2	Lipoprotein(a)IBA 10/2011 - 07/2006
2	sibutramine (Meridia)FDA Link 04/2010 - 03/2010
2	Anti-Obesity Agents (Antiobesity Drugs)IBA 04/2010 - 03/2010
2	Nicotinamide PhosphoribosyltransferaseIBA 01/2010 - 01/2008
2	Infliximab (Remicade)FDA Link 10/2009 - 05/2006
2	AdipokinesIBA 10/2009 - 01/2008
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2009 - 05/2006
2	Dihydrotachysterol (AT 10)IBA 03/2009 - 09/2005
1	Small Interfering RNA (siRNA)IBA 10/2021
1	Apolipoprotein C-IIIIBA 10/2021
1	ISIS 304801IBA 10/2021
1	KetonesIBA 03/2019
1	Angiotensin IIIBA 03/2019
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2019

Therapy/Procedure

6	Therapeutics 01/2019 - 05/2006
2	Glycemic Control 11/2014 - 10/2013